Deutsche Bank Ag\ Biond Vax Pharmaceuticals Ltd. Transaction History
Deutsche Bank Ag\
- $240 Billion
- Q3 2024
Shares
13 transactions
About BiondVax Pharmaceuticals Ltd.
- Ticker BVXV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 18,678,800
- Market Cap $12M
- Description
- BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Götting...